跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Doctaxel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Doctaxel
Approved
STANDARD
Doctaxel
Getwell Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
05ce2d1870880a52
Company
Getwell Pharmaceuticals
Type
Standard
Approval Details
Approval Id
05ce2d1870880a52
Drug Approval Philippines Name
Doctaxel
Product Name
Doctaxel
Registration Number
DRP-5973-01
Brand Name
Doctaxel
Generic Name
Docetaxel (as trihydrate)
Dosage Form
Concentrate Solution for I.V. Infusion
Dosage Strength
80 mg/2mL
Manufacturer
Getwell Pharmaceuticals
Importer
Ambica International Trading Corp
Distributor
Diafarm Inc.
Issuance Date
26 April 2024
Expiry Date
28 January 2030
Pharmacologic Category
Antineoplastic (Taxane)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
05ce2d1870880a52
Type
Standard
Back to Philippines FDA Approvals